Skip to main content

Table 3 Multivariate Analysis of Overall and Recurrence Free Survival

From: Accelerated hypofractionated radiation therapy compared to conventionally fractionated radiation therapy for the treatment of inoperable non-small cell lung cancer

  

Overall Survival

Relapse Free Survival

Variable

Level

HR (95% CI)

p-value (multivariable)

HR (95% CI)

p-value (multivariable)

RT Group (All stages)

STRT1 vs. ACRT

0.764 (0.544-1.074)

0.121

0.649 (0.465-0.904)

0.011

 

STRT2 vs. ACRT

0.885 (0.643-1.219)

0.455

0.848 (0.619-1.162)

0.304

Induction Chemotherapy

Yes vs. No

0.852 (0.637-1.139)

0.280

0.896 (0.675-1.189)

0.445

Initial Weight Loss

≥ 5% vs. < 5%

1.192 (0.909-1.562)

0.205

1.099 (0.842-1.434)

0.488

Age

Each 5 yr

1.122 (1.056-1.193)

< 0.001

1.091 (1.026-1.987)

0.005

Tumor Histology

NSC-NOS vs. Adenocarcinoma

-

-

1.428 (1.026-1.987)

0.035

 

Squamous vs. Adenocarcinoma

-

-

1.180 (0.879-1.584)

0.271

  1. HR: Hazard Ratio; CI: Confidence Interval; RT: Radiation Treatment; NSC-NOS: Non-Small Cell-Not Otherwise Specified
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us